Recombinant Human MAP3K14 Protein ，His & Myc

MAP3K14, also known as MLK3 (Mixed-Lineage Kinase 3), is a member of the mitogen-activated protein kinase (MAPK) signaling cascade, which plays a critical role in various cellular processes, including proliferation, differentiation, and apoptosis. The protein is particularly involved in the activation of the c-Jun N-terminal kinase (JNK) pathway, linking external stress signals to intracellular responses. Research has indicated that dysregulation of MAP3K14 can contribute to numerous diseases, including cancer and neurodegenerative disorders. Given its pivotal role in mediating stress responses and cellular signaling, MAP3K14 has emerged as a promising target for therapeutic intervention. The study of recombinant MAP3K14 proteins allows for a deeper understanding of its functional mechanisms and interactions within the signaling pathways, facilitating the identification of small molecule inhibitors or modulators. Furthermore, understanding the structural characteristics of MAP3K14 through recombinant protein studies can pave the way for innovative drug design strategies, potentially leading to novel treatments for diseases linked to its dysregulation. As researchers continue to elucidate the role of MAP3K14 in various biological contexts, the development of recombinant forms of this protein offers valuable tools for both basic research and pharmaceutical applications.